Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. Common Stock | CUE | $18.95 | $137.66M | — | |
| Atrium Therapeutics, Inc. | RNA | $8.00 | $136.85M | — | |
| Korro Bio, Inc. | KRRO | $9.29 | $136.80M | — | |
| Outlook Therapeutics, Inc. | OTLK | $0.56 | $136.65M | — | |
| AN2 Therapeutics, Inc. | ANTX | $3.60 | $135.85M | — | |
| Organigram Global Inc. | OGI | $0.94 | $135.59M | 2.2 | — |
| Journey Medical Corporation | DERM | $4.80 | $135.48M | — | |
| TuHURA Biosciences, Inc. | HURA | $2.09 | $132.87M | — | |
| Quanterix Corporation Common Stock | QTRX | $2.79 | $131.95M | — | |
| Health Catalyst, Inc. | HCAT | $1.74 | $130.95M | — | |
| Tiziana Life Sciences Ltd | TLSA | $1.01 | $128.53M | — | |
| HLS Therapeutics Inc. | HLS.TO | CA$4.13 | CA$127.76M | — | |
| Organogenesis Holdings Inc. | ORGO | $0.99 | $127.56M | — | |
| Anavex Life Sciences Corp. | AVXL | $1.36 | $126.07M | — | |
| Nkarta, Inc. | NKTX | $1.75 | $125.34M | — | |
| Retension Pharmaceuticals, Inc. | RTSN | $15.00 | $124.97M | — | |
| Voyager Therapeutics, Inc. | VYGR | $2.02 | $124.47M | — | |
| Spruce Biosciences, Inc. | SPRB | $42.73 | $122.81M | — | |
| Definitive Healthcare Corp. | DH | $1.15 | $122.76M | — | |
| Owlet, Inc. | OWLT | $4.20 | $122.73M | — | |
| Cumberland Pharmaceuticals Inc. | CPIX | $8.17 | $122.41M | — | |
| Foghorn Therapeutics Inc. | FHTX | $2.04 | $121.15M | — | |
| BGM Group Ltd. | BGM | $8.24 | $119.79M | — | |
| Black Diamond Therapeutics, Inc. | BDTX | $2.08 | $118.61M | — | |
| Humacyte, Inc. | HUMA | $0.41 | $114.23M | — | |
| Minerva Neurosciences, Inc. | NERV | $2.39 | $114.12M | — | |
| NRx Pharmaceuticals, Inc. | NRXP | $2.63 | $113.87M | — | |
| Armata Pharmaceuticals, Inc. | ARMP | $3.06 | $113.78M | — | |
| Seer, Inc. | SEER | $2.03 | $112.41M | — | |
| Cellectis S.A. | CLLS | $0.97 | $110.81M | — | |
| vTv Therapeutics Inc. | VTVT | $27.77 | $109.80M | — | |
| enGene Therapeutics Inc. | ENGN | $1.63 | $109.24M | — | |
| Cibus, Inc. | CBUS | $1.41 | $107.00M | — | |
| Unicycive Therapeutics, Inc. | UNCY | $3.87 | $106.01M | — | |
| Apyx Medical Corporation | APYX | $2.51 | $105.73M | — | |
| Vivani Medical, Inc. | VANI | $1.16 | $104.64M | — | |
| LifeMD, Inc. | LFMD | $2.14 | $103.27M | — | |
| PolyPid Ltd. | PYPD | $5.07 | $102.98M | — | |
| PMV Pharmaceuticals, Inc. | PMVP | $1.36 | $102.70M | — | |
| Immunic, Inc. | IMUX | $7.48 | $102.06M | — | |
| The Joint Corp. | JYNT | $7.17 | $101.41M | 51.2 | — |
| LENZ Therapeutics, Inc. | LENZ | $3.22 | $101.17M | — | |
| Stereotaxis, Inc. | STXS | $0.99 | $99.69M | — | |
| NeurAxis, Inc. | NRXS | $7.92 | $99.46M | — | |
| Insight Molecular Diagnostics Inc. | IMDX | $3.02 | $98.83M | — | |
| Coya Therapeutics, Inc. | COYA | $4.14 | $97.12M | — | |
| Polaryx Therapeutics, Inc. | PLYX | $1.94 | $96.70M | — | |
| Aardvark Therapeutics, Inc. | AARD | $4.41 | $96.51M | — | |
| ImmuCell Corporation | ICCC | $10.52 | $95.54M | 150.3 | — |
| Charlotte's Web Holdings, Inc. | CWEB.TO | CA$0.35 | CA$94.95M | — |
Cue Biopharma, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $137.66M
- P/E
- unprofitable
Atrium Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.85M
- P/E
- unprofitable
Korro Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.80M
- P/E
- unprofitable
Outlook Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.65M
- P/E
- unprofitable
AN2 Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $135.85M
- P/E
- unprofitable
Organigram Global Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $135.59M
- P/E
- 2.2
Journey Medical Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $135.48M
- P/E
- unprofitable
TuHURA Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $132.87M
- P/E
- unprofitable
Quanterix Corporation Common Stock
Healthcare / Medical Devices
- Market Cap
- $131.95M
- P/E
- unprofitable
Health Catalyst, Inc.
Healthcare / Health Information Services
- Market Cap
- $130.95M
- P/E
- unprofitable
Tiziana Life Sciences Ltd
Healthcare / Biotechnology
- Market Cap
- $128.53M
- P/E
- unprofitable
HLS Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$127.76M
- P/E
- unprofitable
Organogenesis Holdings Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $127.56M
- P/E
- unprofitable
Anavex Life Sciences Corp.
Healthcare / Biotechnology
- Market Cap
- $126.07M
- P/E
- unprofitable
Nkarta, Inc.
Healthcare / Biotechnology
- Market Cap
- $125.34M
- P/E
- unprofitable
Retension Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $124.97M
- P/E
- unprofitable
Voyager Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $124.47M
- P/E
- unprofitable
Spruce Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $122.81M
- P/E
- unprofitable
Definitive Healthcare Corp.
Healthcare / Health Information Services
- Market Cap
- $122.76M
- P/E
- unprofitable
Owlet, Inc.
Healthcare / Medical Devices
- Market Cap
- $122.73M
- P/E
- unprofitable
Cumberland Pharmaceuticals Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $122.41M
- P/E
- unprofitable
Foghorn Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $121.15M
- P/E
- unprofitable
BGM Group Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $119.79M
- P/E
- unprofitable
Black Diamond Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $118.61M
- P/E
- unprofitable
Humacyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $114.23M
- P/E
- unprofitable
Minerva Neurosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $114.12M
- P/E
- unprofitable
NRx Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $113.87M
- P/E
- unprofitable
Armata Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $113.78M
- P/E
- unprofitable
Seer, Inc.
Healthcare / Biotechnology
- Market Cap
- $112.41M
- P/E
- unprofitable
Cellectis S.A.
Healthcare / Biotechnology
- Market Cap
- $110.81M
- P/E
- unprofitable
vTv Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $109.80M
- P/E
- unprofitable
enGene Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $109.24M
- P/E
- unprofitable
Cibus, Inc.
Healthcare / Biotechnology
- Market Cap
- $107.00M
- P/E
- unprofitable
Unicycive Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $106.01M
- P/E
- unprofitable
Apyx Medical Corporation
Healthcare / Medical Devices
- Market Cap
- $105.73M
- P/E
- unprofitable
Vivani Medical, Inc.
Healthcare / Biotechnology
- Market Cap
- $104.64M
- P/E
- unprofitable
LifeMD, Inc.
Healthcare / Health Information Services
- Market Cap
- $103.27M
- P/E
- unprofitable
PolyPid Ltd.
Healthcare / Biotechnology
- Market Cap
- $102.98M
- P/E
- unprofitable
PMV Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $102.70M
- P/E
- unprofitable
Immunic, Inc.
Healthcare / Biotechnology
- Market Cap
- $102.06M
- P/E
- unprofitable
The Joint Corp.
Healthcare / Medical Care Facilities
- Market Cap
- $101.41M
- P/E
- 51.2
LENZ Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $101.17M
- P/E
- unprofitable
Stereotaxis, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $99.69M
- P/E
- unprofitable
NeurAxis, Inc.
Healthcare / Biotechnology
- Market Cap
- $99.46M
- P/E
- unprofitable
Insight Molecular Diagnostics Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $98.83M
- P/E
- unprofitable
Coya Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $97.12M
- P/E
- unprofitable
Polaryx Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $96.70M
- P/E
- unprofitable
Aardvark Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $96.51M
- P/E
- unprofitable
ImmuCell Corporation
Healthcare / Biotechnology
- Market Cap
- $95.54M
- P/E
- 150.3
Charlotte's Web Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$94.95M
- P/E
- unprofitable
Showing 651–700 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.